Is Beav buying that huge OPKO pond? $3 billion size with little sales and red earning? Beav might not like it.. Can you bring us a smaller pick, with little activity now, but promise for growth? Maybe all those typed ponds are already being developed.
CYTK was hit hard this AM on Ph 2 news of their CHF trial with Amgen. The knife is still falling at 7.75 but I'll be putting some speculative dollars there soon. The news wasn't really that bad. They have clearly active molecules for difficult to treat diseases such as ALS and CHF. They have a long ways to go but their science is sound and the spin-off indications for their novel drugs that increase strength are absolutely huge.